Antonio Gómez-Muñoz Selected Research

Antonio Gómez-Muñoz Research Topics

5	Inflammation (Inflammations) 01/2019 - 05/2006
2	Neoplasms (Cancer) 01/2016 - 04/2008
2	Necrosis 05/2006 - 10/2004
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Obesity 10/2020
1	Insulin Resistance 10/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Fatty Liver 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Edema (Dropsy) 03/2016
1	Lung Injury 03/2016
1	Acute Lung Injury 03/2016
1	Pneumonia (Pneumonitis) 06/2015
1	Starvation 03/2012
1	Neoplasm Metastasis (Metastasis) 04/2008
1	Carcinogenesis 04/2008
1	Leukemia 05/2007
1	Colonic Neoplasms (Colon Cancer) 08/2006
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2006
1	Colitis 05/2006
1	Atherosclerotic Plaque (Atheroma) 10/2004

5	CeramidesIBA 01/2021 - 10/2004
4	SphingolipidsIBA 01/2021 - 04/2008
3	EnzymesIBA 01/2021 - 04/2008
2	ceramide 1-phosphateIBA 03/2009 - 04/2008
1	Vitamin E FDA LinkGeneric 01/2019
1	Phosphatidylethanolamine N-MethyltransferaseIBA 01/2019
1	AntioxidantsIBA 01/2019
1	LipopolysaccharidesIBA 03/2016
1	CytokinesIBA 03/2016
1	SmokeIBA 06/2015
1	StaurosporineIBA 03/2012
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2008
1	FenretinideIBA 05/2007
1	Cardiolipins (Cardiolipin)IBA 05/2007
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2007
1	Antineoplastic Agents (Antineoplastics)IBA 05/2007
1	PhytochemicalsIBA 08/2006
1	CurcuminIBA 08/2006
1	Protein Kinases (Protein Kinase)IBA 05/2006
1	Dextrans (Dextran)FDA Link 05/2006
1	Mitogen-Activated Protein KinasesIBA 05/2006
1	JNK Mitogen-Activated Protein KinasesIBA 05/2006
1	AcidsIBA 05/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2006
1	Oxidants (Oxidizing Agents)IBA 05/2006
1	pyrazolanthroneIBA 05/2006
1	SodiumIBA 05/2006
1	SB 203580IBA 05/2006
1	oxidized low density lipoproteinIBA 10/2004
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 10/2004
1	Caspase 3 (Caspase-3)IBA 10/2004
1	Death Domain ReceptorsIBA 10/2004

1	Therapeutics 05/2007